PT  - JOURNAL ARTICLE
AU  - DAISAKU YOSHIDA
AU  - TERUFUMI KUSUNOKI
AU  - YOSHIKI TAKAYAMA
AU  - YOHSUKE KUSANO
AU  - SHINICHI MINOHARA
AU  - KIO KANO
AU  - WATARU ANNO
AU  - KEISUKE TSUCHIDA
AU  - YOSUKE TAKAKUSAGI
AU  - NOBUTAKA MIZOGUCHI
AU  - ITSUKO SERIZAWA
AU  - TAKESHI EBARA
AU  - HIROYUKI KATOH
TI  - Comparison of Dose Distribution Between VMAT-SBRT and Scanning Carbon-ion Radiotherapy for Early-stage NSCLC
AID  - 10.21873/anticanres.15270
DP  - 2021 Sep 01
TA  - Anticancer Research
PG  - 4571--4575
VI  - 41
IP  - 9
4099  - http://ar.iiarjournals.org/content/41/9/4571.short
4100  - http://ar.iiarjournals.org/content/41/9/4571.full
SO  - Anticancer Res2021 Sep 01; 41
AB  - Background/Aim: The purpose of this study was to compare the dose distribution between scanning carbon-ion radiotherapy (sCIRT) and volumetric-modulated arc therapy with stereotactic body radiation therapy (VMAT-SBRT) for stage I non-small cell lung cancer (NSCLC). Patients and Methods: Fifteen patients with early-stage NSCLC who underwent sCIRT at Kanagawa Cancer Center between 2018-2020 were enrolled. Dose-volume histogram parameters of the planned target volume and normal organs for sCIRT and VMAT-SBRT were evaluated. Results: The homogeneity index of the target volume of sCIRT was significantly lower than that of VMAT-SBRT. The dose of sCIRT was significantly lower than that of VMAT-SBRT at low volumes in the lung, heart, spinal cord, and esophagus. Conclusion: The dose distribution of sCIRT for early-stage NSCLC was better than that of VMAT-SBRT.